Purchase Order 36C26325P0831

Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55417, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,000, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the provision of TAVR (Transcatheter Aortic Valve Replacement) products and is structured as a firm fixed-price purchase order. It has an ultimate completion date of June 20, 2025. Edwards Lifesciences LLC is a global leader in medical innovations for...
This is a federal contract award to Edwards Lifesciences LLC, a for-profit limited liability company and small disadvantaged business, by the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The contract, valued at $34,000.00, is for the provision of transcatheter aortic valve replacement (TAVR) products and services. The contract has a firm fixed price pricing type and a period of performance through October 17, 2024. Edwards Lifesciences LLC has received...
This federal contract award, valued at $34,000.00, was issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company that is a subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices designed to enhance surgical and cardiovascular care for veterans. Edwards Lifesciences LLC holds a significant...
This federal contract award is for a Transcatheter Aortic Valve Replacement (TAVR) procedure, awarded to the prime contractor Edwards Lifesciences LLC, a for-profit limited liability company. The contract has a firm-fixed price of $34,000.00 and a completion date of October 29, 2024. The award was made by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network (VISN) 23, to support healthcare services at VA facilities. Edwards Lifesciences LLC is a...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract valued at $34,000.00 to Edwards Lifesciences LLC, a for-profit limited liability company and subsidiary of Edwards Lifesciences Corporation. The contract is for the delivery of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices used to enhance surgical and cardiovascular care for veterans. This award is part of a larger Indefinite Delivery...
This federal contract award is a purchase order valued at $34,000 issued by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company subsidiary of Edwards Lifesciences Corporation, a global leader in medical devices for structural heart disease and critical care monitoring. The contract is for the provision of transcatheter aortic valve replacement (TAVR) products and services, with a period of performance ending on January 22, 2025....
This federal contract award, valued at $32,500.00, was issued by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company, for the delivery of prosthetic cardiac devices including transcatheter aortic valve replacement (TAVR) products. The contract is a firm fixed-price purchase order with a period of performance through March 27, 2025. Edwards Lifesciences LLC, a self-certified...
This federal contract award to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company subsidiary of Edwards Lifesciences Corporation, is for the provision of Transcatheter Aortic Valve Replacement (TAVR) products and services to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The $34,000.00 firm fixed-price purchase order contract has a completion date of March 26, 2025 and was awarded on February 24, 2025 by...
The federal contract award is for the provision of a 29mm Transcatheter Aortic Valve Replacement (TAVR) Kit to the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). The contract was awarded to Edwards Lifesciences LLC, a for-profit limited liability company that specializes in cardiovascular medical devices and services. This $34,000.00 Firm Fixed Price purchase order does not have a set-aside designation and has a completion date of March 12, 2025. Edwards...
This federal contract award to Edwards Lifesciences LLC, a for-profit limited liability company and small disadvantaged business, is for the provision of transcatheter aortic valve replacement (TAVR) products and services. The $34,000 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs and Veterans Health Administration, specifically the Veterans Integrated Service Network 23, to support cardiovascular care for veterans. The contract has an ultimate...

This federal contract award, valued at $34,000.00, was issued by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company. The contract is for the procurement of Transcatheter Aortic Valve Replacement (TAVR) products, which are specialized cardiovascular medical devices used to treat structural heart disease in veterans.

Edwards Lifesciences LLC is the prime contractor and has been awarded multiple contracts and Indefinite Delivery Vehicles (IDVs) by the VA and Veterans Health Administration (VHA) to supply advanced cardiovascular equipment, including transcatheter heart valves, surgical implants, and related technologies. This particular award is structured as a firm fixed-price purchase order and does not have a set-aside designation. The ultimate completion date for this contract is June 2, 2025.

Generated 6/1/25, 2:59 AM